Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 29:
30. The compound of claim 24, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is C3-C4 cycloalkyl, wherein the C3-C4 cycloalkyl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R2b substituents; and
at least one R2b is C6-C14 aryl, wherein the C6-C14 aryl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents; and
each R4a is independently halogen, C1-C6 alkyl, and OR8.